- Complete Tumor Resection for a Hepatocellular Carcinoma Secreting Parathyroid Hormone-related Peptide
-
Kim EK, Kim JS, Shin KC, Lee GT, Han CJ, Kim SB, Ku YH
- KMID: 2373325
- Korean J Gastroenterol.
- 2015 Aug;66(2):122-126.
- doi: 10.4166/kjg.2015.66.2.122
Hepatocellular carcinoma (HCC) is the fifth most common cancer in Korea. Diverse paraneoplastic syndromes can occur in patients with HCC, but parathyroid hormone-related peptide (PTH-rP)-induced hypercalcemia is uncommon. Hypercalcemia due... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative Radiologic and Postoperative Pathologic Risk Factors for Early Intra-Hepatic Recurrence in Hepatocellular Carcinoma Patients Who Underwent Curative Resection
-
Kim H, Park MS, Park YN, Kim H, Kim KS, Choi JS, Ahn SH, Han KH, Kim MJ, Kim KW
- KMID: 1777092
- Yonsei Med J.
- 2009 Dec;50(6):789-795.
- doi: 10.3349/ymj.2009.50.6.789
PURPOSE: The risk of hepatocellular carcinoma (HCC) recurrence must be considered ahead of surgery. This study was undertaken to identify pre-operative risk factors for early intrahepatic recurrence of HCC after... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of P53 on the radiotherapy response of hepatocellular carcinoma
-
Gomes AR, Abrantes A, Brito AF, Laranjo M, Casalta-Lopes JE, Goncalves , Sarmento-Ribeiro AB, Botelho MF, Tralhao JG
- KMID: 2351026
- Clin Mol Hepatol.
- 2015 Sep;21(3):257-267.
- doi: 10.3350/cmh.2015.21.3.257
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
-
Gu HR, Park SC, Choi SJ, Lee JC, Kim YC, Han CJ, Kim J, Yang KY, Kim YJ, Noh GY, No SH, Jeong JH
- KMID: 2155291
- Clin Mol Hepatol.
- 2015 Mar;21(1):49-59.
- doi: 10.3350/cmh.2015.21.1.49
BACKGROUND/AIMS: Silibinin, the main component of silymarin, is used as a hepatoprotectant and exhibits anticancer effects against various cancer cells. This study evaluated the effects of a combination of silibinin... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization
-
Kim SH, Chung YH, Yang SH, Kim JA, Jang MK, Kim SE, Lee D, Lee SH, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ
- KMID: 1374960
- Korean J Hepatol.
- 2009 Sep;15(3):320-330.
- doi: 10.3350/kjhep.2009.15.3.320
BACKGROUND/AIMS: Osteopontin (OPN) is overexpressed in hepatocellular carcinoma (HCC) with postoperative recurrence or extrahepatic metastasis. However, its prognostic value in patients treated with transarterial chemoembolization (TACE) is unclear. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
